Our clients Johnson & Johnson Innovative Medicine and Bayer Healthcare are Category Winners in the 'Facility of the Year' Awards.
We are thrilled to celebrate the success of our clients' projects in these prestigious awards which recognise excellence in pharmaceutical manufacturing facilities. This year’s category winners have set new benchmarks:
Johnson & Johnson Innovative Medicine's BioCork 3.2 expansion project in Ireland has won the project execution category. The project earned accolades for its state-of-the-art facility that supports the production of immunology and oncology treatments. The 2,000 sq.m BioCork 3.2 expansion enhances multi-product manufacturing capabilities. It incorporates advanced digital innovations for superior collaboration and safety. Read more
Bayer Healthcare's Cell Therapy Launch and Manufacturing Facility in Berkeley, California, has won the social impact category. This flexible facility signifies a major advancement in the production and commercialization of innovative cell therapies addressing critical unmet medical needs. It fosters collaboration with biotech innovators, academia, and automation suppliers to expedite the development of transformative therapies. Read more
“These category wins underscore PM Group's commitment to excellence and innovation in pharmaceutical engineering. They reinforce our expertise in delivering complex, high-impact projects. I am incredibly proud of our teams who helped to deliver these world leading projects,” said Jeremy Freeman, Pharmaceutical Sector Director, PM Group.
More about our expertise in the Pharma sector
